Anti-chemokine (CCL2, CCL3, CCL5, CXCL11, CXCL12) single-domain antibodies

Details for Australian Patent Application No. 2007337983 (hide)

Owner Ablynx N.V.

Inventors Saunders, Michael John Scott; Blanchetot, Christophe; De Haard, Johannes Joseph Wilhelmus

Agent Shelston IP

Pub. Number AU-A-2007337983

PCT Pub. Number WO2008/077945

Priority 60/877,050 22.12.06 US

Filing date 21 December 2007

Wipo publication date 3 July 2008

International Classifications

C07K 16/24 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

6 August 2009 PCT application entered the National Phase

  PCT publication WO2008/077945 Priority application(s): WO2008/077945

16 August 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007337994-Oligonucleotide-, protein and/or peptide-polymer conjugates

2007337982-Reinforcing system for reinforcing a cavity of a structural element